rs147838690

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_201384.3(PLEC):​c.5477G>A​(p.Arg1826Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,553,096 control chromosomes in the GnomAD database, including 174 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1826W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.010 ( 21 hom., cov: 34)
Exomes 𝑓: 0.012 ( 153 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.00500
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033517182).
BP6
Variant 8-143924452-C-T is Benign according to our data. Variant chr8-143924452-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 93063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-143924452-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0104 (1574/151388) while in subpopulation NFE AF= 0.0118 (800/67752). AF 95% confidence interval is 0.0111. There are 21 homozygotes in gnomad4. There are 874 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLECNM_201384.3 linkuse as main transcriptc.5477G>A p.Arg1826Gln missense_variant 31/32 ENST00000345136.8 NP_958786.1
PLECNM_201378.4 linkuse as main transcriptc.5435G>A p.Arg1812Gln missense_variant 31/32 ENST00000356346.7 NP_958780.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLECENST00000345136.8 linkuse as main transcriptc.5477G>A p.Arg1826Gln missense_variant 31/321 NM_201384.3 ENSP00000344848 Q15149-4
PLECENST00000356346.7 linkuse as main transcriptc.5435G>A p.Arg1812Gln missense_variant 31/321 NM_201378.4 ENSP00000348702 Q15149-9

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1573
AN:
151280
Hom.:
21
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00221
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00421
Gnomad ASJ
AF:
0.000867
Gnomad EAS
AF:
0.000393
Gnomad SAS
AF:
0.00438
Gnomad FIN
AF:
0.0542
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.0101
GnomAD3 exomes
AF:
0.00930
AC:
1532
AN:
164778
Hom.:
22
AF XY:
0.00929
AC XY:
863
AN XY:
92880
show subpopulations
Gnomad AFR exome
AF:
0.00182
Gnomad AMR exome
AF:
0.00377
Gnomad ASJ exome
AF:
0.00141
Gnomad EAS exome
AF:
0.000383
Gnomad SAS exome
AF:
0.00335
Gnomad FIN exome
AF:
0.0513
Gnomad NFE exome
AF:
0.0121
Gnomad OTH exome
AF:
0.00944
GnomAD4 exome
AF:
0.0115
AC:
16175
AN:
1401708
Hom.:
153
Cov.:
68
AF XY:
0.0113
AC XY:
7827
AN XY:
694956
show subpopulations
Gnomad4 AFR exome
AF:
0.00146
Gnomad4 AMR exome
AF:
0.00364
Gnomad4 ASJ exome
AF:
0.00126
Gnomad4 EAS exome
AF:
0.0000824
Gnomad4 SAS exome
AF:
0.00424
Gnomad4 FIN exome
AF:
0.0485
Gnomad4 NFE exome
AF:
0.0122
Gnomad4 OTH exome
AF:
0.0102
GnomAD4 genome
AF:
0.0104
AC:
1574
AN:
151388
Hom.:
21
Cov.:
34
AF XY:
0.0118
AC XY:
874
AN XY:
74010
show subpopulations
Gnomad4 AFR
AF:
0.00221
Gnomad4 AMR
AF:
0.00420
Gnomad4 ASJ
AF:
0.000867
Gnomad4 EAS
AF:
0.000394
Gnomad4 SAS
AF:
0.00459
Gnomad4 FIN
AF:
0.0542
Gnomad4 NFE
AF:
0.0118
Gnomad4 OTH
AF:
0.0100
Alfa
AF:
0.00905
Hom.:
4
Bravo
AF:
0.00655
ESP6500AA
AF:
0.00211
AC:
4
ESP6500EA
AF:
0.00764
AC:
35
ExAC
AF:
0.00922
AC:
984
Asia WGS
AF:
0.00116
AC:
4
AN:
3460

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024PLEC: BS1, BS2 -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 14, 2019- -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 30, 2016- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:3
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxMar 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 12, 2013- -
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy;C5676875:Junctional epidermolysis bullosa with pyloric atresia Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 02, 2021- -
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.071
.;.;.;.;T;.;.;.;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.49
N
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0034
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.048
T
MutationAssessor
Benign
1.1
.;.;.;.;L;.;.;.;.
MutationTaster
Benign
0.97
D;D;D;D;D;D;D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.1
N;N;N;N;N;N;N;N;N
REVEL
Benign
0.24
Sift
Benign
0.30
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.15
T;T;T;T;T;T;T;T;T
Polyphen
1.0
D;D;D;D;D;D;D;D;.
Vest4
0.29
MVP
0.69
ClinPred
0.011
T
GERP RS
2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.041
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147838690; hg19: chr8-144998620; COSMIC: COSV59617808; API